Introduction | p. 6 |
The Growth of the Pharmaceutical Industry | p. 9 |
Regulation: The Development of the FDA | p. 25 |
The Drug Development Process | p. 37 |
The Drug Approval Process | p. 61 |
The Bottom Line: Corporate Responsibilities to Shareholders | p. 79 |
Shades of Gray: Corporate Ethical Responsibilities | p. 91 |
Further Reading | p. 102 |
For More Information | p. 103 |
Glossary | p. 104 |
Bibliography | p. 107 |
Index | p. 110 |
Picture Credits | p. 111 |
Biographies | p. 112 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.